These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 17308964)

  • 1. Glycemia, triglycerides and disease severity are best associated with higher platelet activity in patients with stable coronary artery disease.
    Osmancik PP; Bednar F; Móciková H
    J Thromb Thrombolysis; 2007 Oct; 24(2):105-7. PubMed ID: 17308964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between changes in platelet reactivity and changes in platelet receptor expression induced by physical exercise.
    Aurigemma C; Fattorossi A; Sestito A; Sgueglia GA; Farnetti S; Buzzonetti A; Infusino F; Landolfi R; Scambia G; Crea F; Lanza GA
    Thromb Res; 2007; 120(6):901-9. PubMed ID: 17337041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships between optical aggregometry (type born) and flow cytometry in evaluating ADP-induced platelet activation.
    Sbrana S; Della Pina F; Rizza A; Buffa M; De Filippis R; Gianetti J; Clerico A
    Cytometry B Clin Cytom; 2008 Jan; 74(1):30-9. PubMed ID: 17630652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to antiplatelet therapy and platelet reactivity to thrombin receptor activating peptide-6 in cardiovascular interventions: Differences between peripheral and coronary angioplasty.
    Gremmel T; Xhelili E; Steiner S; Koppensteiner R; Kopp CW; Panzer S
    Atherosclerosis; 2014 Jan; 232(1):119-24. PubMed ID: 24401225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of platelet fibronectin, ADP-induced platelet aggregation and serum total nitric oxide (NOx) levels in angiographically determined coronary artery disease.
    Ekmekçi H; Işler I; Sönmez H; Gürel C; Ciftçi O; Ulutin T; Kökoğlu E; Domaniç N; Dirican A
    Thromb Res; 2006; 117(3):249-54. PubMed ID: 16378831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Aggregometry with Flow Cytometry for the Assessment of Agonists´-Induced Platelet Reactivity in Patients on Dual Antiplatelet Therapy.
    Gremmel T; Koppensteiner R; Panzer S
    PLoS One; 2015; 10(6):e0129666. PubMed ID: 26058047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The stratification of platelet reactivity and activation in patients with stable coronary artery disease on aspirin therapy.
    Gurbel PA; Bliden KP
    Thromb Res; 2003; 112(1-2):9-12. PubMed ID: 15013266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease.
    Guthikonda S; Alviar CL; Vaduganathan M; Arikan M; Tellez A; DeLao T; Granada JF; Dong JF; Kleiman NS; Lev EI
    J Am Coll Cardiol; 2008 Aug; 52(9):743-9. PubMed ID: 18718422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prasugrel 5 mg inhibits platelet P-selectin and GPIIb-IIIa expression in very elderly and non elderly: results from the GENERATIONS trial, a pharmacodynamic study in stable CAD patients.
    Wagner H; Lood C; Borna C; Gidlöf O; Truedsson L; Brown P; Zhou C; Winters K; Jakubowski JA; Erlinge D
    J Thromb Thrombolysis; 2016 Oct; 42(3):369-75. PubMed ID: 27165280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of platelet sensitization to ADP following discontinuation of clopidogrel therapy in patients with stable coronary artery disease.
    Lordkipanidzé M; Diodati JG; Schampaert E; Palisaitis DA; Pharand C
    Platelets; 2015; 26(6):545-51. PubMed ID: 25167467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of CD40L (CD154) and CD62P (p-selectin) surface expression upon GPIIb-IIIa blockade of platelets from stable coronary artery disease patients.
    Chandler AB; Earhart AD; Speich HE; Kueter TJ; Hansen J; White MM; Jennings LK
    Thromb Res; 2010 Jan; 125(1):44-52. PubMed ID: 19487018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced P-selectin expression on platelet-a marker of platelet activation, in young patients with angiographically proven coronary artery disease.
    George R; Bhatt A; Narayani J; Thulaseedharan JV; Sivadasanpillai H; Tharakan JA
    Mol Cell Biochem; 2016 Aug; 419(1-2):125-33. PubMed ID: 27406211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium-Channel Blockers Attenuate the Antiplatelet Effect of Clopidogrel.
    Gremmel T; Durstberger M; Eichelberger B; Koppensteiner R; Panzer S
    Cardiovasc Ther; 2015 Oct; 33(5):264-9. PubMed ID: 26014752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil and platelet activation in equine recurrent airway obstruction is associated with increased neutrophil CD13 expression, but not platelet CD41/61 and CD62P or neutrophil-platelet aggregate formation.
    Dunkel B; Rickards KJ; Werling D; Page CP; Cunningham FM
    Vet Immunol Immunopathol; 2009 Sep; 131(1-2):25-32. PubMed ID: 19362377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The additive antiplatelet action of clopidogrel in patients with coronary artery disease treated with aspirin.
    Dropinski J; Jakiela B; Sanak M; Wegrzyn W; Biernat M; Dziedzina S; Plutecka H; Szczeklik A
    Thromb Haemost; 2007 Jul; 98(1):201-9. PubMed ID: 17598014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P-selectin (CD62P) and soluble TREM-like transcript-1 (sTLT-1) are associated with coronary artery disease: a case control study.
    Shen L; Yang T; Xia K; Yan Z; Tan J; Li L; Qin Y; Shi W
    BMC Cardiovasc Disord; 2020 Aug; 20(1):387. PubMed ID: 32831023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preserved thrombin-inducible platelet activation in thienopyridine-treated patients.
    Gremmel T; Kopp CW; Seidinger D; Koppensteiner R; Steiner S; Panzer S
    Eur J Clin Invest; 2013 Jul; 43(7):689-97. PubMed ID: 23611368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-thrombotic action of clopidogrel and P1(A1/A2) polymorphism of beta3 integrin in patients with coronary artery disease not being treated with aspirin.
    Dropinski J; Musial J; Jakiela B; Wegrzyn W; Sanak M; Szczeklik A
    Thromb Haemost; 2005 Dec; 94(6):1300-5. PubMed ID: 16411409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mean platelet volume is not associated with platelet reactivity and the extent of coronary artery disease in diabetic patients.
    De Luca G; Verdoia M; Cassetti E; Schaffer A; Di Giovine G; Bertoni A; Di Vito C; Sampietro S; Aimaretti G; Bellomo G; Marino P; Sinigaglia F;
    Blood Coagul Fibrinolysis; 2013 Sep; 24(6):619-24. PubMed ID: 23689272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Greater reduction of platelet activation markers and platelet-monocyte aggregates by prasugrel compared to clopidogrel in stable coronary artery disease.
    Braun OO; Johnell M; Varenhorst C; James S; Brandt JT; Jakubowski JA; Winters KJ; Wallentin L; Erlinge D; Siegbahn A
    Thromb Haemost; 2008 Oct; 100(4):626-33. PubMed ID: 18841285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.